These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 19168260

  • 1. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY, Choi W, Shin SS, Lee SW, Ahn SD, Kim JH, Je HU, Park CI, Lee JS, Choi EK.
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [Abstract] [Full Text] [Related]

  • 2. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R.
    Acta Oncol; 2006 Oct; 45(7):787-95. PubMed ID: 16982541
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
    Hiraoka M, Matsuo Y, Nagata Y.
    Cancer Radiother; 2007 Oct; 11(1-2):32-5. PubMed ID: 17158081
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
    Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):1146-50. PubMed ID: 19800181
    [Abstract] [Full Text] [Related]

  • 5. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):707-15. PubMed ID: 18455322
    [Abstract] [Full Text] [Related]

  • 6. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W, Tomé WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, Weigel T, Mehta MP.
    Acta Oncol; 2006 Nov 01; 45(7):890-6. PubMed ID: 16982555
    [Abstract] [Full Text] [Related]

  • 7. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE.
    J Clin Oncol; 2009 Apr 01; 27(10):1579-84. PubMed ID: 19255320
    [Abstract] [Full Text] [Related]

  • 8. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K, Jones DR.
    J Thorac Cardiovasc Surg; 2010 Sep 01; 140(3):583-9. PubMed ID: 20478576
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
    Fritz P, Kraus HJ, Blaschke T, Mühlnickel W, Strauch K, Engel-Riedel W, Chemaissani A, Stoelben E.
    Lung Cancer; 2008 May 01; 60(2):193-9. PubMed ID: 18045732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
    Takeda A, Kunieda E, Sanuki N, Ohashi T, Oku Y, Sudo Y, Iwashita H, Ooka Y, Aoki Y, Shigematsu N, Kubo A.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):363-9. PubMed ID: 19427552
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, Jeremic B.
    Lung Cancer; 2005 Apr 01; 48(1):107-14. PubMed ID: 15777977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB, Grills IS, Kestin LL, Robertson JM.
    Am J Clin Oncol; 2011 Oct 01; 34(5):494-8. PubMed ID: 20805737
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
    Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):344-9. PubMed ID: 19765913
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
    Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, Ikenaga S, Araki T, Uematsu M.
    Lung Cancer; 2004 Jul 01; 45(1):45-55. PubMed ID: 15196734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.